Pertussis vaccination in adults: a behavioral study of physicians from the US, France, and Germany.

IF 2 Q2 MEDICINE, GENERAL & INTERNAL
Donald Middleton, Liana Clark, Anne Mosnier, Ulrich Heininger
{"title":"Pertussis vaccination in adults: a behavioral study of physicians from the US, France, and Germany.","authors":"Donald Middleton, Liana Clark, Anne Mosnier, Ulrich Heininger","doi":"10.1186/s12875-024-02647-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pertussis is a highly contagious respiratory tract infection that affects all ages, though it is most severe in young infants. Adults, especially those with respiratory conditions or other chronic illnesses can also suffer serious consequences of pertussis. Pertussis vaccination is the best method of disease prevention in a lifetime. This behavioral study aimed to assess physicians' attitudes towards pertussis vaccination in adults and the importance of pertussis vaccination for disease prevention, especially in those with chronic illnesses, and to determine the impact of the COVID-19 pandemic on adult vaccination behaviors.</p><p><strong>Methods: </strong>Between November 2022 and January 2023, physicians from the US, France, and Germany registered in an independent online database were contacted to participate in this study. After eligibility screening, participating physicians completed an online questionnaire addressing topics related to physician recommendations and vaccination behavior around pertussis in adults.</p><p><strong>Results: </strong>Eight hundred physicians participated in the study (US: 400; France: 200; Germany: 200). Physicians' attitudes towards pertussis vaccination in adults were broadly similar between the countries. Overall, 65% of physicians believed in the importance of vaccination against pertussis, a lower proportion than for COVID-19 (82%), influenza (81%), pneumococcal disease (76%), and tetanus (73%). Physicians considered immunocompromised adults or those with chronic obstructive pulmonary disease (COPD), asthma, or other respiratory conditions to be at greatest risk from pertussis. Physicians estimated that two-thirds of the adult patients to whom they recommended pertussis vaccination agreed to receive it. The top reason why they felt patients did not receive pertussis vaccination as recommended was low perception of personal risk for pertussis. Physicians' pertussis vaccination behavior was found to be similar before and after the COVID-19 pandemic.</p><p><strong>Conclusions: </strong>While physicians in the surveyed countries recognized the value of pertussis vaccination in adults, they ranked its importance lower than that of other adult vaccines. Physicians recognized the need to immunize vulnerable adults who are at risk of severe pertussis, such as those with asthma and/or COPD, but this awareness frequently did not result in vaccination of these priority groups, especially without official recommendations to support such vaccination in these groups.</p>","PeriodicalId":72428,"journal":{"name":"BMC primary care","volume":"25 1","pages":"402"},"PeriodicalIF":2.0000,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11590461/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC primary care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s12875-024-02647-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Pertussis is a highly contagious respiratory tract infection that affects all ages, though it is most severe in young infants. Adults, especially those with respiratory conditions or other chronic illnesses can also suffer serious consequences of pertussis. Pertussis vaccination is the best method of disease prevention in a lifetime. This behavioral study aimed to assess physicians' attitudes towards pertussis vaccination in adults and the importance of pertussis vaccination for disease prevention, especially in those with chronic illnesses, and to determine the impact of the COVID-19 pandemic on adult vaccination behaviors.

Methods: Between November 2022 and January 2023, physicians from the US, France, and Germany registered in an independent online database were contacted to participate in this study. After eligibility screening, participating physicians completed an online questionnaire addressing topics related to physician recommendations and vaccination behavior around pertussis in adults.

Results: Eight hundred physicians participated in the study (US: 400; France: 200; Germany: 200). Physicians' attitudes towards pertussis vaccination in adults were broadly similar between the countries. Overall, 65% of physicians believed in the importance of vaccination against pertussis, a lower proportion than for COVID-19 (82%), influenza (81%), pneumococcal disease (76%), and tetanus (73%). Physicians considered immunocompromised adults or those with chronic obstructive pulmonary disease (COPD), asthma, or other respiratory conditions to be at greatest risk from pertussis. Physicians estimated that two-thirds of the adult patients to whom they recommended pertussis vaccination agreed to receive it. The top reason why they felt patients did not receive pertussis vaccination as recommended was low perception of personal risk for pertussis. Physicians' pertussis vaccination behavior was found to be similar before and after the COVID-19 pandemic.

Conclusions: While physicians in the surveyed countries recognized the value of pertussis vaccination in adults, they ranked its importance lower than that of other adult vaccines. Physicians recognized the need to immunize vulnerable adults who are at risk of severe pertussis, such as those with asthma and/or COPD, but this awareness frequently did not result in vaccination of these priority groups, especially without official recommendations to support such vaccination in these groups.

成人百日咳疫苗接种:对美国、法国和德国医生的行为研究。
背景:百日咳是一种传染性极强的呼吸道传染病,各年龄段均可感染,但以婴幼儿最为严重。成年人,尤其是患有呼吸道疾病或其他慢性疾病的人也会受到百日咳的严重影响。接种百日咳疫苗是一生中预防疾病的最佳方法。这项行为研究旨在评估医生对成人接种百日咳疫苗的态度以及接种百日咳疫苗对预防疾病(尤其是慢性病患者)的重要性,并确定 COVID-19 大流行对成人接种行为的影响:方法:2022 年 11 月至 2023 年 1 月期间,我们联系了在独立在线数据库中注册的美国、法国和德国的医生参与本研究。经过资格筛选后,参与研究的医生填写了一份在线调查问卷,内容涉及医生建议和成人百日咳疫苗接种行为:共有 800 名医生参与了研究(美国:400 人;法国:200 人;德国:200 人)。各国医生对成人百日咳疫苗接种的态度大体相似。总体而言,65% 的医生认为接种百日咳疫苗很重要,这一比例低于 COVID-19(82%)、流感(81%)、肺炎球菌疾病(76%)和破伤风(73%)。医生认为,免疫力低下的成年人或患有慢性阻塞性肺病(COPD)、哮喘或其他呼吸道疾病的人感染百日咳的风险最大。据医生估计,他们推荐接种百日咳疫苗的成年患者中有三分之二同意接种。他们认为患者没有按照建议接种百日咳疫苗的首要原因是对百日咳的个人风险认识不足。在 COVID-19 大流行前后,医生的百日咳疫苗接种行为相似:结论:尽管受调查国家的医生认识到成人接种百日咳疫苗的价值,但他们对百日咳疫苗重要性的排名低于其他成人疫苗。医生们认识到有必要为易感染严重百日咳的成年人接种疫苗,如患有哮喘和/或慢性阻塞性肺病的人,但这种认识往往不会导致为这些重点人群接种疫苗,尤其是在没有官方建议支持为这些人群接种疫苗的情况下。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信